143 related articles for article (PubMed ID: 2106908)
1. Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.
Melegh B; Kerner J; Jaszai V; Bieber LL
Biochem Med Metab Biol; 1990 Feb; 43(1):30-8. PubMed ID: 2106908
[TBL] [Abstract][Full Text] [Related]
2. Pivampicillin-promoted excretion of pivaloylcarnitine in humans.
Melegh B; Kerner J; Bieber LL
Biochem Pharmacol; 1987 Oct; 36(20):3405-9. PubMed ID: 3675603
[TBL] [Abstract][Full Text] [Related]
3. Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man.
Melegh B; Sumegi B; Sherry AD
Xenobiotica; 1993 Nov; 23(11):1255-61. PubMed ID: 8310709
[TBL] [Abstract][Full Text] [Related]
4. Relationship of carnitine and carnitine precursors lysine, epsilon-N-trimethyllysine, and gamma-butyrobetaine in drug-induced carnitine depletion.
Melegh B; Pap M; Bock I; Rebouche CJ
Pediatr Res; 1993 Oct; 34(4):460-4. PubMed ID: 8255678
[TBL] [Abstract][Full Text] [Related]
5. Carnitine content of red blood cells of human subjects treated with pivampicillin and carnitine.
Melegh B; Jászai V
Acta Paediatr Hung; 1991; 31(2):255-61. PubMed ID: 1867892
[TBL] [Abstract][Full Text] [Related]
6. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.
Holme E; Greter J; Jacobson CE; Lindstedt S; Nordin I; Kristiansson B; Jodal U
Lancet; 1989 Aug; 2(8661):469-73. PubMed ID: 2570185
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine replacement therapy in chronic valproate treatment.
Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A
Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456
[TBL] [Abstract][Full Text] [Related]
8. Plasma and urine free L-carnitine in human diabetes mellitus.
De Palo E; Gatti R; Sicolo N; Padovan D; Vettor R; Federspil G
Acta Diabetol Lat; 1981; 18(1):91-5. PubMed ID: 7211090
[TBL] [Abstract][Full Text] [Related]
9. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate.
Frohlich J; Seccombe DW; Hahn P; Dodek P; Hynie I
Metabolism; 1978 May; 27(5):555-61. PubMed ID: 642827
[TBL] [Abstract][Full Text] [Related]
10. Formation of pivaloylcarnitine in isolated rat heart cells.
Diep QN; Brørs O; Bøhmer T
Biochim Biophys Acta; 1995 Nov; 1259(2):161-5. PubMed ID: 7488636
[TBL] [Abstract][Full Text] [Related]
11. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy.
Murakami K; Sugimoto T; Nishida N; Kobayashi Y; Kuhara T; Matsumoto I
Brain Dev; 1992 May; 14(3):178-81. PubMed ID: 1514659
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
Chalmers RA; Roe CR; Stacey TE; Hoppel CL
Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
[TBL] [Abstract][Full Text] [Related]
13. Carnitine disposition before and during valproate therapy in patients with epilepsy.
Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
[TBL] [Abstract][Full Text] [Related]
14. Carnitine administration ameliorates the changes in energy metabolism caused by short-term pivampicillin medication.
Melegh B; Pap M; Molnár D; Masszi G; Kopcsányi G
Eur J Pediatr; 1997 Oct; 156(10):795-9. PubMed ID: 9365072
[TBL] [Abstract][Full Text] [Related]
15. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
[TBL] [Abstract][Full Text] [Related]
16. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
[TBL] [Abstract][Full Text] [Related]
17. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance.
Thurston JH; Carroll JE; Hauhart RE; Schiro JA
Life Sci; 1985 Apr; 36(17):1643-51. PubMed ID: 3921791
[TBL] [Abstract][Full Text] [Related]
18. Oral L-carnitine administration after jejunoileal by-pass surgery.
Seccombe D; Burget D; Frohlich J; Hahn P; Cleator I; Gourlay RH
Int J Obes; 1984; 8(5):427-33. PubMed ID: 6519903
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic valproic acid treatment on plasma and urine carnitine levels in children: decreased urinary excretion.
Melegh B; Kerner J; Kispál G; Acsádi G; Dani M
Acta Paediatr Hung; 1987; 28(2):137-42. PubMed ID: 3122798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
